Related posts
Oil and stocks climb on earnings week3 Best U.S. Healthcare ETFsOur 3 defensive healthcare stocks picksThis summary was created by AI, based on 4 opinions in the last 12 months.
Becton Dickinson (BDX-N) is a healthcare supplier with a strong presence in North America and global exposure. The company has a good dividend, is held by institutions, and has steady earnings. With 90% of its products being disposable, Becton Dickinson has a steady stream of recurring revenue. The company is expected to see double-digit earnings growth and has a strong M&A strategy. Overall, experts believe that Becton Dickinson offers a good investment opportunity due to its cheap valuation and promising future.
Avoid TMO because their revenues are flattening. Both trade at a high PE. BDX hasn't done much in share movement. He'd rather pay more for Boston Scientific which performs better.
Share have been flattened, but it's now cheap. They tell a good story.
They have incredible reach with 90% of hospital patients touching one of their surgical and medical products
Pays a good dividend, is held by institutions, great earnings and has global exposure.
Healthcare supplier in North America.
90% of products are disposable - creates recurring revenue.
Expecting double digit earnings growth.
Fantastic M&A growth with good management team.
Dividend growing at a regular pace.
"Canadian Tire" of healthcare products for clinics and medical offices. Products are one-use only. Elective surgeries have been cancelled, so stock has not done much. Will shine in post-Covid era. Yield is 1.38%. (Analysts’ price target is $272.31)
Becton Dickinson is a American stock, trading under the symbol BDX-N on the New York Stock Exchange (BDX). It is usually referred to as NYSE:BDX or BDX-N
In the last year, 5 stock analysts published opinions about BDX-N. 4 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Becton Dickinson.
Becton Dickinson was recommended as a Top Pick by on . Read the latest stock experts ratings for Becton Dickinson.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
5 stock analysts on Stockchase covered Becton Dickinson In the last year. It is a trending stock that is worth watching.
On 2024-07-26, Becton Dickinson (BDX-N) stock closed at a price of $237.3.
Still really likes it. Major issue was surgeries on hold during Covid. Revenues declined, now returning to growth. Free cashflow yield ~4.5%. Earnings growth should return to double digits by end of 2024 and into the next couple of years. Unique. Compelling value.